• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

美国食品药品监督管理局（FDA）对具有致畸风险药物的分类。致畸学会公共事务委员会。

FDA classification of drugs for teratogenic risk. Teratology Society Public Affairs Committee.

出版信息

Teratology. 1994 Jun;49(6):446-7. doi: 10.1002/tera.1420490603.

DOI:10.1002/tera.1420490603
PMID:7747265
Abstract

The Teratology Society believes that the current FDA Use-in-Pregnancy Ratings should be abandoned. The Society recommends that drug labeling should include narrative statements that summarize and interpret available data regarding hazards of developmental toxicity and provide estimates of potential teratogenic risk.

摘要

畸形学协会认为，美国食品药品监督管理局（FDA）目前的孕期用药评级应予废止。该协会建议，药品标签应包含叙述性声明，总结并解释有关发育毒性危害的现有数据，并提供潜在致畸风险的评估。

相似文献

1
FDA classification of drugs for teratogenic risk. Teratology Society Public Affairs Committee.美国食品药品监督管理局（FDA）对具有致畸风险药物的分类。致畸学会公共事务委员会。
Teratology. 1994 Jun;49(6):446-7. doi: 10.1002/tera.1420490603.
2
Potential human teratogenicity of frequently prescribed drugs.
Obstet Gynecol. 1990 Apr;75(4):594-9.
3
Report of the Teratology Society Public Affairs Committee symposium on FDA classification of drugs.致畸学协会公共事务委员会关于美国食品药品监督管理局药物分类研讨会的报告
Teratology. 1993 Jul;48(1):5-6. doi: 10.1002/tera.1420480103.
4
Teratology public affairs committee position paper: Pregnancy labeling for prescription drugs: Ten years later.畸形学公共事务委员会立场文件：处方药的孕期用药标签：十年之后
Birth Defects Res A Clin Mol Teratol. 2007 Sep;79(9):627-30. doi: 10.1002/bdra.20389.
5
Human teratogens: update 2010.人类致畸物：2010年更新
Birth Defects Res A Clin Mol Teratol. 2011 Jan;91(1):1-7. doi: 10.1002/bdra.20748. Epub 2011 Jan 6.
6
Food and Drug Administration proposed testing guidelines for developmental toxicity studies. Revision Committee. FDA Guidelines for Developmental Toxicity and Reproduction, Food and Drug Administration.美国食品药品监督管理局提出了发育毒性研究的测试指南。修订委员会。美国食品药品监督管理局《发育毒性与生殖指南》
Regul Toxicol Pharmacol. 1999 Aug;30(1):39-44. doi: 10.1006/rtph.1999.1307.
7
Risk classification systems for drug use during pregnancy: are they a reliable source of information?孕期药物使用风险分类系统：它们是可靠的信息来源吗？
Drug Saf. 2000 Sep;23(3):245-53. doi: 10.2165/00002018-200023030-00006.
8
Teratology Public Affairs Committee position paper: maternal obesity and pregnancy.畸形学公共事务委员会立场文件：孕妇肥胖与妊娠
Birth Defects Res A Clin Mol Teratol. 2006 Feb;76(2):73-7. doi: 10.1002/bdra.20236.
9
The U.S. Food and Drug Adminstration (FDA) has assigned pregnancy category D to valproate.美国食品药品监督管理局（FDA）已将丙戊酸盐的妊娠安全性分类定为D类。
N C Med J. 2010 Jul-Aug;71(4):396-8.
10
Regulatory aspects of teratology: role of the Food and Drug Administration.畸形学的监管方面：美国食品药品监督管理局的作用
Teratology. 1982 Apr;25(2):193-9. doi: 10.1002/tera.1420250208.

引用本文的文献

1
Advancing Glaucoma Treatment During Pregnancy and Breastfeeding: Contemporary Management Strategies and Prospective Therapeutic Developments.孕期及哺乳期青光眼治疗进展：当代管理策略与前瞻性治疗进展
Biomedicines. 2024 Nov 25;12(12):2685. doi: 10.3390/biomedicines12122685.
2
Multiple Vertebral Compression Fractures Secondary to Pregnancy-induced Osteoporosis: A Case Report.妊娠性骨质疏松继发多节段椎体压缩性骨折：一例报告
J Orthop Case Rep. 2024 Jun;14(6):101-107. doi: 10.13107/jocr.2024.v14.i06.4518.
3
Successful Management of Bilateral Uncontrolled Advanced Primary Open Angle Glaucoma in a Pregnant Woman during the Restrictive COVID-19 Lockdown.
在新冠疫情封锁限制期间成功治疗一名孕妇双侧未控制的晚期原发性开角型青光眼
Clin Optom (Auckl). 2024 Mar 27;16:101-105. doi: 10.2147/OPTO.S451799. eCollection 2024.
4
Latest Concepts in Endodontic Management of Pregnant Patients.孕妇牙髓病治疗的最新理念
Int J Dent. 2023 Sep 26;2023:9714515. doi: 10.1155/2023/9714515. eCollection 2023.
5
A double blind, randomised, placebo-controlled trial to evaluate the efficacy of metformin to treat preterm pre-eclampsia (PI2 Trial): study protocol.一项评估二甲双胍治疗早产先兆子痫（PI2 试验）疗效的双盲、随机、安慰剂对照试验：研究方案。
BMJ Open. 2019 Apr 24;9(4):e025809. doi: 10.1136/bmjopen-2018-025809.
6
Glaucoma medications in pregnancy.孕期青光眼药物治疗
Oman J Ophthalmol. 2018 Sep-Dec;11(3):195-199. doi: 10.4103/ojo.OJO_212_2017.
7
European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 3: Treatment principles and options Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 3 Treatment principles and options.《欧洲青光眼协会青光眼术语与指南》第4版 - 第3章：治疗原则与选择 由欧洲青光眼协会基金会支持：第1部分：前言；引言；术语表；第3章治疗原则与选择
Br J Ophthalmol. 2017 Jun;101(6):130-195. doi: 10.1136/bjophthalmol-2016-EGSguideline.003.
8
Double blind, randomised, placebo-controlled trial to evaluate the efficacy of esomeprazole to treat early onset pre-eclampsia (PIE Trial): a study protocol.双盲、随机、安慰剂对照试验以评估埃索美拉唑治疗早发型子痫前期的疗效（PIE试验）：一项研究方案
BMJ Open. 2015 Oct 28;5(10):e008211. doi: 10.1136/bmjopen-2015-008211.
9
The rights and wrongs of blood-brain barrier permeability studies: a walk through 100 years of history.血脑屏障通透性研究的是与非：百年历史回顾
Front Neurosci. 2014 Dec 16;8:404. doi: 10.3389/fnins.2014.00404. eCollection 2014.
10
Developing a systematic approach to safer medication use during pregnancy: summary of a Centers for Disease Control and Prevention--convened meeting.制定孕期用药安全的系统方法：疾病控制与预防中心召集会议总结
Am J Obstet Gynecol. 2014 Sep;211(3):208-214.e1. doi: 10.1016/j.ajog.2014.05.040. Epub 2014 May 29.